Corline Biomedical AB
STO:CLBIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Corline Biomedical AB
STO:CLBIO
|
SE |
|
Origin Agritech Ltd
NASDAQ:SEED
|
CN |
|
Hargreaves Services PLC
LSE:HSP
|
UK |
|
Meiko Network Japan Co Ltd
TSE:4668
|
JP |
|
Corbion NV
F:CSUA
|
NL |
|
Erdene Resource Development Corp
F:E8K
|
CA |
|
H
|
Honghua Group Ltd
XMUN:4HB
|
CN |
|
Tailim Packaging Co Ltd
KRX:011280
|
KR |
|
Shoals Technologies Group Inc
NASDAQ:SHLS
|
US |
|
T
|
Tourism Enterprise Company (Shams) SJSC
SAU:4170
|
SA |
|
V
|
Vibhavadi Medical Center PCL
SET:VIBHA
|
TH |
|
Tekmar Group PLC
F:6UA
|
UK |
|
Fuse Group Holding Inc
OTC:FUST
|
US |
|
C
|
Caledonia Mining Corporation PLC
AMEX:CMCL
|
JE |
|
A
|
Australian Rare Earths Ltd
ASX:AR3
|
AU |
Intrinsic Value
Is CLBIO undervalued or overvalued?
See the intrinsic value estimate for Corline Biomedical AB and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
CLBIO looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with CLBIO’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Corline Biomedical AB Does
Corline Biomedical AB engages in the business of developing a portfolio of drug candidates for use in connection with organ and cell transplantation. The company employs 12 full-time employees The company went IPO on 2015-06-03. The company develops, manufactures and markets heparin-based solutions to improve kidney transplantation, cell therapies and applications in regenerative medicine.
- Headquarters
- Sweden SE
- Employees
- 13
- IPO date
- Jun 3, 2015
Revenue & Expenses Breakdown
Corline Biomedical AB
Earnings Waterfall
Corline Biomedical AB
The intrinsic value for Corline Biomedical AB (CLBIO) under the Base Case is hidden SEK.
Compared with the current market price of 13.7 SEK, the stock appears hidden.